Topical foam treatment for seborrheic dermatitis launches in US
Dermatology biopharma company Arcutis has launched ZORYVE, a topical foam for the treatment of seborrheic dermatitis, in the United States for individuals 9 years of age and older.
Archives for January 23, 2024
PlaqueTec and Babraham Institute collaborate on phenotypic screen of coronary artery blood
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), and the Flow Cytometry Facility at the Babraham Institute have announced a collaboration to develop a bespoke cell phenotyping...
Vesper Bio awarded grant by Michael J. Fox Foundation to assess sortilin inhibitors for Parkinson’s disease
Danish biotech company Vesper Bio has been awarded a grant worth $873,000 by The Michael J. Fox Foundation (MJFF) to assess sortilin inhibition in Parkinson’s disease.